The FDA signed off on a second generic option for the abortion pill mifepristone on Tuesday, hours before most of the federal government shut down and despite Republican opposition to the drug. Evita ...

This marks the second approval of the abortion drug mifepristone, which was initially approved under the brand name Mifeprex in 2000 under the Clinton administration. Since then, mifepristone, along ...

Generic drugmaker Lupin has launched Rivaroxaban for Oral Suspension, 1 mg/mL, in the U.S. The product is bioequivalent to Xarelto for Oral Suspension, 1 mg/mL of Janssen Pharmaceuticals, Inc.

The US Food and Drug Administration (USFDA) approved a higher number of generic drugs in FY25, which ended on September 30, than it did in the previous year, signalling a steady appetite for ...

Adderall is a central nervous system stimulant that's prescribed to treat two conditions, attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. If you're ...

President Donald Trump announced on Thursday (September 25, 2025) a 100% tariff on branded and patented pharmaceutical imports, effective October 1, 2025, unless companies establish manufacturing ...

In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. AbbVie Inc. stands second among them. AbbVie Inc. (NYSE:ABBV), a global biopharmaceutical leader known for ...

There are a lot of tutorials to get through early in Dying Light: The Beast. Many of them are helpful as you learn the ins and outs of the mechanics, but after a few hours, they can become an ...

Biocon is aiming to support its generics business while complementing the momentum of its biosimilars segment. The company has expanded its U.S. operations with the opening of a manufacturing facility ...

The settlement agreement will extend market exclusivity for AbbVie’s JAK inhibitor in the U.S. until 2037—providing pediatric exclusivity is granted. AbbVie has reached a settlement with generic ...

AbbVie ABBV-0.56%decrease; red down pointing triangle has struck a deal with generic drugmakers aimed at extending patent protection for its blockbuster autoimmune drug Rinvoq well into the next ...